Study Overview - Clinical Trial Results .org

Baseline CharacteristicsCharacteristicApixabanN=161JapanWarfarinN=175ApixabanN=9120GlobalWarfarinN=9081Age, median 71 70 70 70Women, % 22 21 35 35CHADS2, mean 2.0 2.0 2.1 2.11, % 42 40 34 342, % 26 31 36 36≥ 3, % 32 28 30 30Risk factors, %Age ≥75 yrs 33 34 31 31Prior stroke, TIA, SE 25 27 19 20Heart failure or reduced LV EF 18 23 35 36Diabetes 29 21 25 25Hypertension 78 76 87 88Renal function (Cl Cr ml/min), %Normal (>80) 22 17 41 41Mild impairment (>50 – 80) 53 58 42 42Moderate impairment (>30 – 50) 23 23 15 15Severe impairment (≤ 30) 2.5 2.3 1.5 1.5